What HRV actually measures
Heart rate variability (HRV) is the variation in time between successive heartbeats (R-R intervals). Counter-intuitively, higher HRV is generally a marker of better health and adaptability — a heart that varies its beat-to-beat timing is one that is responding flexibly to physiological demands, not a sign of arrhythmia.
HRV reflects the balance between the sympathetic nervous system (“fight or flight”) and the parasympathetic nervous system (“rest and digest”). High parasympathetic tone is associated with high resting HRV; high sympathetic activation or chronic stress is associated with reduced HRV.
Time-domain vs frequency-domain
HRV is computed from R-R interval time series in two principal ways:
- Time-domain measures — RMSSD (root mean square of successive differences) is the most commonly cited, especially for short-term and resting measurements. SDNN (standard deviation of N-N intervals) is also widely used, particularly for 24-hour recordings.
- Frequency-domain measures — power spectrum analysis decomposes HRV into frequency bands: HF (high frequency, 0.15–0.4 Hz, mainly parasympathetic), LF (0.04–0.15 Hz, mixed), and VLF (very low frequency, < 0.04 Hz, less clearly mapped to autonomic branches).
What influences HRV
- Age — HRV declines progressively with age, more sharply after the fifth decade.
- Fitness — aerobic exercise training typically increases resting HRV in the medium term, though acute exercise decreases HRV temporarily.
- Sleep — sleep architecture strongly influences HRV, with higher parasympathetic tone (higher HRV) during deep sleep.
- Stress — both acute and chronic psychological stress reduce HRV.
- Autonomic neuropathies — diabetic autonomic neuropathy and other conditions that damage autonomic nerves reduce HRV.
- Medications — beta-blockers and other autonomic drugs can substantially modify readings.
- Caffeine, alcohol, hydration, posture — all measurable influences on short-term HRV.
HRV and disease risk
Reduced HRV is an independent predictor of mortality after myocardial infarction, and is associated with increased risk of several chronic conditions in epidemiological studies. The Framingham Heart Study and other large cohorts have documented this association over decades of follow-up.
The predictive value of HRV at the population level does not necessarily translate into actionable information for an individual. HRV is sensitive to many inputs, and the signal-to-noise ratio for short-term measurements is high. Trends over weeks or months are more informative than single-day readings.
The “recovery” framing in biohacking
Many wearable devices now report HRV-based “recovery scores” or “readiness scores.” The premise: by tracking overnight HRV (and sometimes resting heart rate, sleep staging, and respiratory rate), a fitness-fatigue balance can be inferred, and training or stress-management interventions can be optimised.
The underlying physiology is real: HRV does reflect autonomic state, and autonomic state does reflect recovery and stress. The implementation question — whether a specific score, from a specific device, predicts specific outcomes better than simpler metrics — is less well-established.
Independent validation of consumer HRV-based metrics is sparse. The algorithm details are typically proprietary, and the relationship between the score and an underlying physiological state is often not publicly documented.
How researchers actually measure HRV
In research settings, HRV is measured from ECG recordings (the gold standard) or photoplethysmography (PPG, the basis of most wearable devices). ECG-derived HRV is more accurate, particularly for frequency-domain measures. PPG-derived HRV is generally acceptable for time-domain measures in resting conditions, but less reliable during movement.
Standardised measurement conditions matter. The Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology published HRV measurement standards in 1996 that remain the most-cited reference. They specify recording length, posture, breathing patterns, and analysis windows.
What HRV cannot do
HRV is not a diagnostic test. It is not specific to any disease, it is not a measure of “adrenal fatigue” or any other alternative-medicine concept, and it does not by itself justify any intervention. A single low HRV reading does not diagnose a problem; a single high reading does not rule one out.
Limits of consumer HRV devices
- Algorithm opacity — proprietary “readiness” scores are not independently reproducible.
- Sensor noise — wrist-based PPG is sensitive to motion, perfusion, and skin tone. Acute readings during daily activity are unreliable.
- Day-to-day variability — even at constant physiological baseline, beat-to-beat and minute-to-minute HRV varies substantially.
- Clinical vs consumer accuracy — consumer-grade devices are typically validated against ECG in narrow conditions, not in the full range of daily use.
How to use HRV as a biomarker
If you choose to track HRV:
- Use a consistent measurement protocol — same time of day, same posture, same device, same duration.
- Track trends over weeks, not single readings.
- Compare against your own baseline, not against generic population norms.
- Pair HRV with other markers — sleep quality, resting heart rate, training load, mood — rather than treating it as a standalone number.
- Do not change medical management based on consumer HRV alone.
The bottom line
HRV is a legitimate physiological biomarker with well-established research behind it. The autonomic nervous system does influence health outcomes, and HRV does reflect autonomic state. The translation into consumer-facing “recovery scores” is less rigorously validated than the underlying science, and the predictive value of any single score depends on the algorithm, the measurement protocol, and the user’s individual baseline.